Articoli con mandati relativi all'accesso pubblico - Mara ArtibaniUlteriori informazioni
Disponibili pubblicamente: 17
Promises and challenges of adoptive T-cell therapies for solid tumours
M Morotti, A Albukhari, A Alsaadi, M Artibani, JD Brenton, SM Curbishley, ...
British journal of cancer 124 (11), 1759-1776, 2021
Mandati: US National Institutes of Health, Cancer Research UK, UK Medical Research …
An evolving story of the metastatic voyage of ovarian cancer cells: cellular and molecular orchestration of the adipose-rich metastatic microenvironment
T Motohara, K Masuda, M Morotti, Y Zheng, S El-Sahhar, KY Chong, ...
Oncogene 38 (16), 2885-2898, 2019
Mandati: Cancer Research UK, UK Medical Research Council, National Institute for …
The repertoire of serous ovarian cancer non-genetic heterogeneity revealed by single-cell sequencing of normal fallopian tube epithelial cells
Z Hu, M Artibani, A Alsaadi, N Wietek, M Morotti, T Shi, Z Zhong, ...
Cancer cell 37 (2), 226-242. e7, 2020
Mandati: Cancer Research UK, UK Engineering and Physical Sciences Research Council …
Genome and epigenome engineering CRISPR toolkit for in vivo modulation of cis-regulatory interactions and gene expression in the chicken embryo
RM Williams, U Senanayake, M Artibani, G Taylor, D Wells, AA Ahmed, ...
Development 145 (4), 2018
Mandati: UK Medical Research Council
WT1expression in breast cancer disrupts the epithelial/mesenchymal balance of tumour cells and correlates with the metabolic response to docetaxel
M Artibani, AH Sims, J Slight, S Aitken, A Thornburn, M Muir, VG Brunton, ...
Scientific Reports, 2017
Mandati: UK Biotechnology and Biological Sciences Research Council, Breast Cancer Now …
Transcription factor Wilms’ tumor 1 regulates developmental RNAs through 3′ UTR interaction
R Bharathavikru, T Dudnakova, S Aitken, J Slight, M Artibani, ...
Genes & development 31 (4), 347-352, 2017
Mandati: UK Biotechnology and Biological Sciences Research Council, UK Medical …
Premalignant SOX2 overexpression in the fallopian tubes of ovarian cancer patients: Discovery and validation studies
K Hellner, F Miranda, DF Chedom, S Herrero-Gonzalez, DM Hayden, ...
EBioMedicine 10, 137-149, 2016
Mandati: US National Institutes of Health, Cancer Research UK, UK Medical Research …
Mechanistic drivers of Müllerian duct development and differentiation into the oviduct
L Santana Gonzalez, IA Rota, M Artibani, M Morotti, Z Hu, N Wietek, ...
Frontiers in Cell and Developmental Biology 9, 605301, 2021
Mandati: US National Institutes of Health, UK Biotechnology and Biological Sciences …
WT1 expression in vessels varies with histopathological grade in tumour-bearing and control tissue from patients with breast cancer
RJ McGregor, YY Chau, TJ Kendall, M Artibani, N Hastie, PWF Hadoke
British Journal of Cancer 119 (12), 1508-1517, 2018
Mandati: UK Medical Research Council, Wellcome Trust
The Oxford classic links epithelial-to-mesenchymal transition to immunosuppression in poor prognosis ovarian cancers
Z Hu, P Cunnea, Z Zhong, H Lu, OI Osagie, L Campo, M Artibani, K Nixon, ...
Clinical Cancer Research 27 (5), 1570-1579, 2021
Mandati: Cancer Research UK, Myrovlytis Trust, UK, National Institute for Health …
Adipocyte-like signature in ovarian cancer minimal residual disease identifies metabolic vulnerabilities of tumor-initiating cells
M Artibani, K Masuda, Z Hu, PC Rauher, G Mallett, N Wietek, M Morotti, ...
JCI insight 6 (11), e147929, 2021
Mandati: US National Institutes of Health, Villum Foundation, Cancer Research UK …
Studying Müllerian duct anomalies–from cataloguing phenotypes to discovering causation
L Santana González, M Artibani, AA Ahmed
Disease Models & Mechanisms 14 (6), dmm047977, 2021
Mandati: UK Biotechnology and Biological Sciences Research Council, National …
Enhanced immunogenicity of mitochondrial-localized proteins in cancer cells
G Prota, U Gileadi, M Rei, AV Lechuga-Vieco, JL Chen, S Galiani, ...
Cancer Immunology Research 8 (5), 685-697, 2020
Mandati: Cancer Research UK, UK Medical Research Council, National Institute for …
A highly accurate platform for clone-specific mutation discovery enables the study of active mutational processes
EM Carrami, S Sharifzadeh, NC Wietek, M Artibani, S El-Sahhar, ...
Elife 9, e55207, 2020
Mandati: US National Institutes of Health, Cancer Research UK, National Institute for …
Single-cell transcriptomics identifies a WNT7A-FZD5 signaling axis that maintains fallopian tube stem cells in patient-derived organoids
A Alsaadi, M Artibani, Z Hu, N Wietek, M Morotti, LS Gonzalez, M Alazzam, ...
Cell Reports 42 (11), 2023
Mandati: National Institute for Health Research, UK
3D Microtumors Representing Ovarian Cancer Minimal Residual Disease Respond to the Fatty Acid Oxidation Inhibitor Perhexiline
X Yang, M Artibani, Y Jin, A Aggarwal, Y Zhang, S Muñoz‐Galvan, ...
Advanced Healthcare Materials, 2404072, 2025
Mandati: Cancer Research UK, European Commission
A 3D microtumour system that faithfully represents ovarian cancer minimal residual disease
X Yang, M Artibani, Y Jin, A Aggarwal, Y Zhang, S Muñoz-Galvan, ...
bioRxiv, 2023.07. 15.549155, 2023
Mandati: Cancer Research UK, European Commission
Le informazioni sulla pubblicazione e sul finanziamento vengono stabilite automaticamente da un software